Jürgen Flöge
Hat mitgewirkt an:
-
Effects of sucroferric oxyhydroxide and sevelamer carbonate on chronic kidney disease : mineral bone disorder parameters in dialysis patients
-
Long‐term efficacy and safety of sucroferric oxyhydroxide in African American dialysis patients
-
Gas6 protein: its role in cardiovascular calcification
-
Characteristics of Patients Who Achieve Serum Phosphorus Control on Sucroferric Oxyhydroxide or Sevelamer Carbonate: A post hoc Analysis of a Phase 3 Study